Skip to content
akaturk Academic measurement
Search

Article detail · 2021 · article

The role of anakinra in the modulation of intestinal cell apoptosis and inflammatory response during ischemia/reperfusion

ISSN1300-0144
YÖKSİS OpenAlex Open access · diamond TR Index
Year2021
Citations8OpenAlex
Percentile%54.7
FWCI0.451.00 = world average
Scopus (SJR)Q3
WoS (JCR)Q3

Data source split

  • YÖKSİSYÖKSİS article record
  • YÖKSİS venueTurkish Journal of Medical Sciences
  • Catalog match (ISSN)Turkish Journal of Medical Sciences
  • OpenAlexOpenAlex enrichment (abstract, citations, topics)

Abstract

OpenAlex English

Background/aim: Even though interleukin-1 receptor antagonist, IL-1Ra, is used in certain inflammatory diseases, its effect on ischemia-reperfusion injury is a current research topic. We aimed to investigate the protective effects of anakinra, an IL-1Ra, on the I/R induced intestinal injury. Materials and methods: The rat model of intestinal ischemia-reperfusion was induced. Rats were randomized into 4 groups: (group 1) control group, (group 2) I/R group, (group 3 and 4) treatment groups (50 mg/kg and 100 mg/kg, respectively). Gene expressions of caspase-3, TNF-α, IL-1α, IL-6, and apoptotic cells in tissue samples were evaluated by PCR and TUNEL methods, respectively. Plasma levels of superoxide dismutase (SOD), catalase (CAT), and malondialdehyde (MDA) were studied by the ELISA method and tissue samples were examined histopathologically as well. Results: Anakinra inhibited the expression of IL-1α, IL-6, and TNF-α and decreased the SOD, CAT, and MDA caused by ischemia- reperfusion injury in both treatment groups. Caspase-3 expression and TUNEL-positive cell number in treatment groups were also less. Histopathologically, anakinra better preserved the villous structure of the small intestine at a dose of 100 mg/kg than 50 mg/kg. Conclusion: Anakinra decreased the intestinal damage caused by ischemia-reperfusion and a dose of 100 mg/kg was found to be histopathologically more effective.

Topics

Citations

OpenAlex cited_by_count. Not a WoS or Scopus citation count; those sources have no separate column here.

8citationsOpenAlex · cited_by_count (cache / database)

14 publications in the local catalog that cite this work (OpenAlex reference match; not the full global list).

  1. 2023 The Effect of Antioxidant Astaxanthin on Intestinal Ischemia Reperfusion Damage in RatsCitations 4 · OpenAlex
  2. 2023 The Effect of Antioxidant Astaxanthin on Intestinal Ischemia Reperfusion Damage in RatsCitations 4 · OpenAlex
  3. 2023 The Effect of Antioxidant Astaxanthin on Intestinal Ischemia Reperfusion Damage in RatsCitations 4 · OpenAlex
  4. 2023 The Effect of Antioxidant Astaxanthin on Intestinal Ischemia Reperfusion Damage in RatsCitations 4 · OpenAlex
  5. 2023 The Effect of Antioxidant Astaxanthin on Intestinal Ischemia Reperfusion Damage in RatsCitations 4 · OpenAlex
  6. 2023 The Effect of Antioxidant Astaxanthin on Intestinal Ischemia Reperfusion Damage in RatsCitations 4 · OpenAlex
  7. 2023 Effect of anakinra, tocilizumab, and the combination thereof on bladder ischemia-reperfusion damage in albino Wistar-type rats.Citations 4 · OpenAlex
  8. 2023 Effect of anakinra, tocilizumab, and the combination thereof on bladder ischemia- reperfusion damage in albino Wistar-type rats.Citations 4 · OpenAlex
  9. 2023 Effect of anakinra, tocilizumab, and the combination thereof on bladder ischemia-reperfusion damage in albino Wistar-type ratsCitations 4 · OpenAlex
  10. 2025 Mitigating Post-Subarachnoid Hemorrhage Complications: Anti-Inflammatory and Anti-Apoptotic Effects of Anakinra in an Experimental StudyCitations 3 · OpenAlex

Authors

6
  1. MUHAMMED KANDEMİR 1
  2. NECDET FATİH YAŞAR 2
  3. METE ÖZKURT 3
  4. RUMEYSA ÖZYURT 4
  5. nuriye ezgi bektur aykanat 5
  6. NİLÜFER ERKASAP ESKİŞEHİR OSMANGAZİ ÜNİVERSİTESİ 6